Psoriasis uncovered - measuring burden of disease impact in a survey of Australians with psoriasis

被引:21
作者
Baker, Chris S. [1 ,2 ,3 ]
Foley, Peter A. [1 ,2 ,3 ]
Braue, Anna [3 ,4 ]
机构
[1] St Vincents Hosp, Dept Dermatol, Melbourne, Vic, Australia
[2] Univ Melbourne, Dept Med Dermatol, Melbourne, Vic, Australia
[3] Skin & Canc Fdn Inc, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Dermatol, Melbourne, Vic, Australia
关键词
Australia; burden of disease; psoriasis; treatment; quality of life; QUALITY-OF-LIFE; COST-EFFECTIVENESS ANALYSIS;
D O I
10.1111/ajd.12010
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/Objectives Internationally, the understanding of psoriasis has advanced in recent years to the point now where it is no longer considered a benign or cosmetic skin condition but a systemic, immune-mediated disease associated with significant comorbidities and considerable detriment to quality of life. The aim of this study was to gain a better understanding of the physical, psychosocial and medical burden of psoriasis on Australian adults and the impact on health status. Methods Two large-scale multi-centre cross-sectional studies of Australian adults with psoriasis were conducted during 2010 and 2011, with the participation of a national patient representative group (Psoriasis Australia). The studies were based on detailed questionnaires that were self-completed by individuals with psoriasis. Results A total of 362 and 330 completed surveys were received in 2010 and 2011, respectively. A significant physical, psychosocial and medical burden was reported by the respondents. It was noteworthy that patients reported actively concealing their disease from the general public (83%), work colleagues (65%), friends (58%), employers (49%), family (40%), close friends (39%) and spouse/partner (20%). The mean five-dimension European quality of life (EQ-5D) score for the 2011 cohort was 0.73, representing a significant impact on their HRQoL. The presence of comorbidities, found in three-quarters of the cohort, was associated with an even greater detriment to their HRQoL (mean score 0.64). Conclusions Psoriasis imposes a significant psychosocial burden on the lives of patients, including a profound impact upon their personal and professional relationships, social interactions and quality of life, to a degree comparable to other serious chronic conditions. This study highlights the importance of collaboration between primary and specialist health-care providers in developing patient management strategies that address the spectrum of physical and psychological manifestations associated with psoriasis.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 20 条
[1]   Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol - In the treatment of mild to moderate plaque psoriasis [J].
Ashcroft, DM ;
Po, ALW ;
Williams, HC ;
Griffiths, CEM .
PHARMACOECONOMICS, 2000, 18 (05) :469-476
[2]  
Australian Bureau of Statistics, 2010, NAT HLTH SURV SUMM R
[3]   Quality of life in patients with psoriasis [J].
Bhosle, Monali J. ;
Kulkarni, Amit ;
Feldman, Steven R. ;
Balkrishnan, Rajesh .
HEALTH AND QUALITY OF LIFE OUTCOMES, 2006, 4 (1)
[4]   Quality of life issues in psoriasis [J].
Choi, J ;
Koo, JYM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (02) :S57-S61
[5]   Comparative Effectiveness of ST-Segment-Elevation Myocardial Infarction Regionalization Strategies [J].
Concannon, Thomas W. ;
Kent, David M. ;
Normand, Sharon-Lise ;
Newhouse, Joseph P. ;
Griffith, John L. ;
Cohen, Joshua ;
Beshansky, Joni R. ;
Wong, John B. ;
Aversano, Thomas ;
Selker, Harry P. .
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2010, 3 (05) :506-513
[6]   Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial [J].
Curran, Desmond ;
Pozzo, Carmelo ;
Zaluski, Jerzy ;
Dank, Magdalena ;
Barone, Carlo ;
Valvere, Vahur ;
Yalcin, Suayib ;
Peschel, Christian ;
Wenczl, Miklos ;
Goker, Erdem ;
Bugat, Roland .
QUALITY OF LIFE RESEARCH, 2009, 18 (07) :853-861
[7]  
Dolan P, 1996, HEALTH ECON, V5, P141, DOI 10.1002/(SICI)1099-1050(199603)5:2<141::AID-HEC189>3.0.CO
[8]  
2-N
[9]   Psoriasis comorbidities [J].
Gottlieb, Alice B. ;
Chao, Chun ;
Dann, Frank .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2008, 19 (01) :5-21
[10]   A classification of psoriasis vulgaris according to phenotype [J].
Griffiths, C. E. M. ;
Christophers, E. ;
Barker, J. N. W. N. ;
Chalmers, R. J. G. ;
Chimenti, S. ;
Krueger, G. G. ;
Leonardi, C. ;
Menter, A. ;
Ortonne, J. -P. ;
Fry, L. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (02) :258-262